Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Amgen divulges novel PI3Kdelta inhibitors

Oct. 29, 2013

Five Prime provides update on two antibody candidates entering phase I trials

Oct. 28, 2013

Epirus and Orygen Biotecnologia sign collaboration agreement for biotechnology products in Brazil

Oct. 24, 2013

FDA approves subcutaneous formulation of Actemra for rheumatoid arthritis

Oct. 23, 2013

Daiichi Sankyo synthesizes new antinflammatory agents

Oct. 22, 2013

FDA approves Cimzia for ankylosing spondylitis, issues complete response letter for axSpA

Oct. 21, 2013

Daiichi Sankyo synthesizes new EP2 inhibitors

Oct. 16, 2013

Otrexup injection approved by the FDA for several indications

Oct. 15, 2013

Xencor's XmAb-5871 advances to second phase of rheumatoid arthritis study

Oct. 3, 2013

Japanese team prepares new BTK inhibitors

Oct. 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...